118 related articles for article (PubMed ID: 2632072)
41. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
42. Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models.
Sirotnak FM; Schmid FA; Otter GM; Piper JR; Montgomery JA
Cancer Res; 1988 Oct; 48(20):5686-91. PubMed ID: 3167828
[TBL] [Abstract][Full Text] [Related]
43. Organoammonium hydroselenites: antitumor action through radical balance regulation.
Arsenyan P; Shestakova I; Rubina K; Domracheva I; Nesterova A; Vosele K; Pudova O; Lukevics E
Eur J Pharmacol; 2003 Apr; 465(3):229-35. PubMed ID: 12681434
[TBL] [Abstract][Full Text] [Related]
44. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
45. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
47. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
[TBL] [Abstract][Full Text] [Related]
48. The in Vitro and in Vivo Antitumor Activities of Tetracyclic Triterpenoids Compounds Actein and 26-Deoxyactein Isolated from Rhizome of Cimicifuga foetida L.
Wu D; Yao Q; Chen Y; Hu X; Qing C; Qiu M
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483235
[TBL] [Abstract][Full Text] [Related]
49. The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe.
Lohmeyer M; Workman P
Biochem Pharmacol; 1993 Jan; 45(1):77-86. PubMed ID: 8424826
[TBL] [Abstract][Full Text] [Related]
50. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
51. The synthesis and antitumor activity of twelve galloyl glucosides.
Li CW; Dong HJ; Cui CB
Molecules; 2015 Jan; 20(2):2034-60. PubMed ID: 25633333
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
53. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
54. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
Hoffman DR; Hoffman LH; Snyder F
Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
[TBL] [Abstract][Full Text] [Related]
55. Antitumor activity of a new compound, ethyl O-[N-(p-carboxyphenyl)-carbamoyl]-mycophenolate, against various experimental tumors upon oral administration.
Mitsui H; Matsuno T; Ogawa H; Shiio T; Yugari Y; Tamura G
Gan; 1981 Feb; 72(1):66-71. PubMed ID: 7274650
[TBL] [Abstract][Full Text] [Related]
56. A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C.
van Blitterswijk WJ; van der Bend RL; Kramer IM; Verhoeven AJ; Hilkmann H; de Widt J
Lipids; 1987 Nov; 22(11):842-6. PubMed ID: 3444375
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and cytotoxic activity of tetrahydropyridylidene-2- and -4-sulfonamides.
Ho LK; Knaus EE; Allen TM; Fathi-Afshar R
Drug Des Deliv; 1989 Jan; 4(1):35-43. PubMed ID: 2775445
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity.
Guillonneau C; PierréA ; Charton Y; Guilbaud N; Kraus-Berthier L; Léonce S; Michel A; Bisagni E; Atassi G
J Med Chem; 1999 Jun; 42(12):2191-203. PubMed ID: 10377224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
